Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · Real-Time Price · USD
11.01
-0.17 (-1.52%)
Dec 20, 2024, 4:00 PM EST - Market closed
Delcath Systems Employees
Delcath Systems had 76 employees as of December 31, 2023. The number of employees increased by 24 or 46.15% compared to the previous year.
Employees
76
Change (1Y)
24
Growth (1Y)
46.15%
Revenue / Employee
$297,947
Profits / Employee
-$449,000
Market Cap
352.03M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ZimVie | 2,600 |
AngioDynamics | 748 |
REGENXBIO | 344 |
Sana Biotechnology | 328 |
Absci | 155 |
Y-mAbs Therapeutics | 100 |
Olema Pharmaceuticals | 74 |
Design Therapeutics | 58 |
DCTH News
- 19 days ago - Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer - Business Wire
- 4 weeks ago - Delcath Begins Platform Expansion With Two Phase 2 Trials - Seeking Alpha
- 4 weeks ago - Delcath Systems: Q3 Earnings Reveal HEPZATO KIT And CHEMOSAT Growth - Seeking Alpha
- 6 weeks ago - Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Delcath Systems Reports Third Quarter 2024 Results and Business Highlights - Business Wire
- 7 weeks ago - Delcath Systems to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Delcath Systems to Host Third Quarter 2024 Earnings Call - Business Wire
- 2 months ago - Delcath Systems Announces Preliminary Third Quarter 2024 Revenue Results - Business Wire